4//SEC Filing
Preston Heather 4
Accession 0001209191-22-038773
CIK 0001805890other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 7:16 PM ET
Size
5.3 KB
Accession
0001209191-22-038773
Insider Transaction Report
Form 4
Preston Heather
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-14+17,000→ 17,000 totalExercise: $3.60Exp: 2032-06-13→ Common Stock (17,000 underlying)
Footnotes (1)
- [F1]This option fully vests on the earlier of (i) June 14, 2023 or (ii) the 2023 Annual Meeting of Shareholders of Fusion Pharmaceuticals Inc.
Documents
Issuer
Fusion Pharmaceuticals Inc.
CIK 0001805890
Entity typeother
Related Parties
1- filerCIK 0001606826
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 7:16 PM ET
- Size
- 5.3 KB